AMPLATZER PFO Occluder Post Approval Study
A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 1214 participants.
Also called NCT03309332
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose prevention
- Phase
- Not applicable
- Enrolled
- 1,214 participants
- Sponsor
- Registry
-
NCT03309332
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States, Canada, Germany, Italy, Portugal, Switzerland, United Kingdom
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT03309332. Allocation not applicable; no masking; primary purpose prevention. Start 2018-01-31 (actual); primary completion 2030-02-05 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- AMPLATZER PFO Occluder Post Approval Study
- Acronym
- PFO PAS
- Condition
- Stroke
- Condition
- Patent Foramen Ovale
- Intervention (Device)
- AMPLATZER™ PFO Occluder
- Lead sponsor
- Abbott Medical Devices
Record details
- Record id
cardio:ct-nct03309332- Content hash
b6a70c9698798da0ff756d97c79e50365940652c6482e64c1ccd6ff38b975496